| Breakdown | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 79.74B | 78.62B | 73.42B | 78.50B | 71.75B |
| Gross Profit | 8.52B | 8.70B | 8.11B | 8.53B | 7.78B |
| EBITDA | 4.10B | 7.52B | 7.06B | 7.81B | 7.66B |
| Net Income | 6.33B | 4.91B | 3.73B | 3.76B | 5.26B |
Balance Sheet | |||||
| Total Assets | 119.30B | 117.45B | 112.77B | 115.83B | 108.99B |
| Cash, Cash Equivalents and Short-Term Investments | 11.30B | 11.83B | 12.48B | 25.27B | 21.23B |
| Total Debt | 27.75B | 30.33B | 27.41B | 37.87B | 36.31B |
| Total Liabilities | 50.86B | 52.11B | 50.14B | 57.96B | 55.33B |
| Stockholders Equity | 68.37B | 64.38B | 61.74B | 57.07B | 53.34B |
Cash Flow | |||||
| Free Cash Flow | 4.00B | 212.00M | -680.00M | 5.51B | 5.38B |
| Operating Cash Flow | 5.74B | 6.35B | 5.83B | 6.73B | 6.03B |
| Investing Cash Flow | 317.00M | -6.01B | -6.94B | -2.74B | -868.00M |
| Financing Cash Flow | -6.67B | -1.41B | -11.69B | -2.04B | -3.69B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | ¥87.27B | 60.23 | ― | 3.48% | 1.42% | 32.92% | |
70 Outperform | ¥14.29B | 9.45 | ― | 3.85% | 8.49% | 32.73% | |
67 Neutral | ¥70.88B | 11.67 | ― | 3.63% | 0.60% | 10.27% | |
65 Neutral | ¥534.62B | 8.48 | 13.93% | 2.81% | -3.74% | 81.14% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
62 Neutral | ¥307.18B | 26.94 | ― | 1.28% | 6.67% | 10.43% | |
59 Neutral | ¥297.34B | 17.48 | ― | 2.94% | 1.47% | -10.54% |